<DOC>
	<DOC>NCT00040638</DOC>
	<brief_summary>The purpose of this study is to determine the effectiveness of TLK286 in the treatment of advanced non-small cell lung cancer.</brief_summary>
	<brief_title>Phase 2 Study of TLK286 Administered Weekly in Advanced Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Histologic or cytologic diagnosis of nonsmall cell lung carcinoma Progressed while on or after treatment on platinumbased regimen Patients may not have had more than one prior cytotoxic chemotherapy regimen Stage IV or IIIB Age at least 18 years Adequate liver and kidney function Adequate bone marrow function Pregnancy or lactation Unstable medical conditions Chemotherapy, hormonal therapy, radiotherapy, radiopharmaceuticals or immunotherapy within 3 weeks of TLK286 CNS metastasis unless controlled by treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>